Nanotechnology in bladder cancer: current state of development and clinical practice

Nanomedicine (Lond). 2015;10(7):1189-201. doi: 10.2217/nnm.14.212.

Abstract

Nanotechnology is being developed for the diagnosis and treatment of both nonmyoinvasive bladder cancer (NMIBC) and invasive bladder cancer. The diagnostic applications of nanotechnology in NMIBC mainly focus on tumor identification during endoscopy to increase complete resection of bladder cancer while nanotechnology to capture malignant cells or their components continues to be developed. The therapeutic applications of nanotechnology in NMIBC are to reformulate biological and cytotoxic agents for intravesical instillation, combine both diagnostic and therapeutic application in one nanoformulation. In invasive and advanced bladder cancer, magnetic resonance imaging with supraparamagnetic iron oxide nanoparticles can improve the sensitivity and specificity in detecting small metastasis to lymph nodes. Nanoformulation of cytotoxic agents can potentially decrease the toxicity while increasing efficacy.

Keywords: bladder cancer; nanoparticle; photodynamic diagnosis; photodynamic therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Drug Delivery Systems / methods*
  • Humans
  • Nanomedicine / methods
  • Nanoparticles / chemistry
  • Nanotechnology / methods
  • Photochemotherapy / methods*
  • Photosensitizing Agents / administration & dosage
  • Urinary Bladder / drug effects
  • Urinary Bladder / pathology*
  • Urinary Bladder Neoplasms / diagnosis*
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Antineoplastic Agents
  • Photosensitizing Agents